I am 3 months pregnant. I got a severe ear infection and the doctor gave me Augmentin.
Yesterday I went for check up at my OB/GYN and when I told him about the Augmentin he was very unhappy and seemed concerned, he said he wishes I’d asked him first… then he said there is nothing to worry about. I am very worried, I’d rather become deaf than harm my baby 
I wonder if anyone can help me with info about augmentin and pregnancy. Thank you.
Did anyone take augmentin while pregnant?
Previous post: major allergy issues. possible remedies?
Next post: Percent change of original permeability?
{ 2 comments… read them below or add one }
Always trust your doctor, they really know, if you don’t trust him better get another one, they spend a lot of time learning and I do not believe they’d like to harm you and the baby. I still checked on the internet for you and Augmentin is told to be safe during pregnancy follow this link if you wish to read about it
http://antibiotics.emedtv.com/augmentin/augmentin-and-pregnancy.html
Andrew E. CzeizelabCorresponding Author Informationemail address, Magda Rockenbauerab, Henrik T. Sørensenab, Jørn Olsenab
Received 14 August 2000; received in revised form 14 August 2000; accepted 22 November 2000.
Abstract
Objective: To study the human teratogenic potential of augmentin (amoxicillin+clavulanic acid) treatment during pregnancy. Materials and methods: Pair analysis of cases with different congenital abnormalities and their matched controls in the population-based dataset of the Hungarian Case-Control Surveillance of Congenital Abnormalities, between 1991 and 1996. Results: The case group included 6935 pregnant women who had offspring with congenital abnormalities, while the control group consisted of 10,238 pregnant women who had babies without any defects. The number (and rate) of pregnant women with augmentin treatment was 52 (0.75%) and 56 (0.55%) in the case and control groups, respectively (crude odds ratio (OR) with 95% confidence interval (CI) was 1.4, 0.9–2.0). The comparison of augmentin treatments during the second-third months of pregnancy (i.e. in the critical period for most major congenital abnormalities) in case-control pairs did not show a higher use of augmentin in any congenital abnormality group. Conclusion: Augmentin treatment of pregnant women in usual therapeutic doses is unlikely to increase the risk of congenital abnormalities in newborn infants. However, the number of cases and controls was limited, therefore, further multicenter-multinational studies are needed for the final risk assessment.
Keywords: Augmentin (amoxicillin+clavulanic acid), Human teratogenic potential, Congenital abnormalities, Case-control analysis